SKB264

Clinical trials for SKB264 explained in plain language.

Never miss a new study

Get alerted when new SKB264 trials appear

Sign up with your email to follow new studies for SKB264, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo offers hope for breast cancer patients who failed leading therapy

Disease control Recruiting now

This study tests a combination of two drugs, SKB264 and inetetamab, in people with advanced HER2-positive breast cancer whose disease got worse after treatment with T-DXd. The goal is to see if this new combination can shrink tumors. About 48 adults will take part in this single-…

Matched conditions: SKB264

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jun 05, 2026 12:07 UTC

SKB264

Get alerted when new SKB264 trials appear

New combo offers hope for breast cancer patients who failed leading therapy